Faculty of Medicine, Department of Urology, University of Antwerpen, Wilrijk, Edegem, Belgium.
Neurourol Urodyn. 2010 Mar;29(3):391-4. doi: 10.1002/nau.20785.
The C-fiber-mediated bladder-cooling reflex and the determination of the current perception thresholds (CPTs) permit to investigate afferent LUT pathways. They have both been proposed to detect and differentiate neurologic bladder dysfunction. This study evaluates, prospectively, the effect of oxybutynin, an antimuscarinic with direct antispasmodic effect on smooth muscle, on repeated ice water test (IWT) and CPTs in patients with a known incomplete neurogenic bladder.
Patients with a known incomplete lesion of the bladder innervation, detrusor overactivity during cystometric bladder filling and a continuous positive response to repeated IWT were included. After the initial tests, 30 mg intravesical oxybutynin (1 mg/ml) was instilled and left in the bladder for 15 min. Afterwards CPTs and IWT were re-assessed.
After the drug application, the bladder-cooling reflex could not be initiated, even after three instillations, in 16/17 patients. The bladder CPT increased from 29.7 +/- 11.3 to 39.1 +/- 15.7 mA after oxybutynin (P = 0.001). No difference was found in CPT of the left forearm (P = 0.208).
Intravesical oxybutynin blocks the bladder-cooling reflex and increases but does not block CPT sensation in the bladder in most patients with incomplete neurogenic lesion and detrusor overactivity. These results help explain the clinical effect of intravesical oxybutynin in neurogenic patients. They also indicate that a pharmacological local influence on C-fiber-related activity can give different clinical effects.
C 纤维介导的膀胱冷却反射和电流感知阈值(CPTs)的测定允许研究传入的 LUT 通路。它们都被提议用于检测和区分神经源性膀胱功能障碍。本研究前瞻性评估了具有直接平滑肌抗痉挛作用的抗毒蕈碱药物奥昔布宁对已知不完全性神经源性膀胱患者重复冰水试验(IWT)和 CPT 的影响。
纳入已知膀胱支配神经不完全损伤、膀胱测压充盈时逼尿肌过度活动且对重复 IWT 持续阳性反应的患者。初始测试后,将 30mg 膀胱内奥昔布宁(1mg/ml)注入并保留在膀胱中 15 分钟。然后重新评估 CPT 和 IWT。
药物应用后,17 例患者中有 16 例即使经过三次灌注也无法引发膀胱冷却反射。奥昔布宁后膀胱 CPT 从 29.7±11.3 增加至 39.1±15.7mA(P=0.001)。左前臂 CPT 无差异(P=0.208)。
在大多数伴有不完全性神经源性损伤和逼尿肌过度活动的患者中,膀胱内奥昔布宁阻断膀胱冷却反射并增加但不阻断膀胱 CPT 感觉。这些结果有助于解释膀胱内奥昔布宁在神经源性患者中的临床效果。它们还表明,对 C 纤维相关活动的药理学局部影响可能产生不同的临床效果。